Martinez-Hernandez L, Lopez-Vera E, Aguilar M
Toxins (Basel). 2024; 16(12.
PMID: 39728762
PMC: 11728717.
DOI: 10.3390/toxins16120504.
Turcio R, Di Matteo F, Capolupo I, Ciaglia T, Musella S, Di Chio C
Mar Drugs. 2024; 22(8).
PMID: 39195466
PMC: 11355921.
DOI: 10.3390/md22080350.
Moriguchi R, Matsuoka K
Cells. 2024; 13(14.
PMID: 39056752
PMC: 11275109.
DOI: 10.3390/cells13141170.
Peigneur S, Tibery D, Tytgat J
Membranes (Basel). 2024; 14(5).
PMID: 38786948
PMC: 11123039.
DOI: 10.3390/membranes14050114.
AlShammari A, Abd El-Aziz T, Al-Sabi A
Toxins (Basel). 2024; 16(1).
PMID: 38251229
PMC: 10820993.
DOI: 10.3390/toxins16010012.
Discovery of an Insect Neuroactive Helix Ring Peptide from Ant Venom.
Barasse V, Jouvensal L, Boy G, Billet A, Ascoet S, Lefranc B
Toxins (Basel). 2023; 15(10).
PMID: 37888631
PMC: 10610885.
DOI: 10.3390/toxins15100600.
Structure of the voltage-gated potassium channel K1.3: Insights into the inactivated conformation and binding to therapeutic leads.
Chandy K, Sanches K, Norton R
Channels (Austin). 2023; 17(1):2253104.
PMID: 37695839
PMC: 10496531.
DOI: 10.1080/19336950.2023.2253104.
Of Seven New K Channel Inhibitor Peptides of , α-KTx 2.24 Has a Picomolar Affinity for Kv1.2.
Shakeel K, Olamendi-Portugal T, Naseem M, Becerril B, Zamudio F, Delgado-Prudencio G
Toxins (Basel). 2023; 15(8).
PMID: 37624263
PMC: 10467108.
DOI: 10.3390/toxins15080506.
Enhancement of SARS-CoV-2 receptor-binding domain activity by two microbial defensins.
Gao B, Zhu S
Front Microbiol. 2023; 14:1195156.
PMID: 37405160
PMC: 10315472.
DOI: 10.3389/fmicb.2023.1195156.
Genomic, functional and structural analyses elucidate evolutionary innovation within the sea anemone 8 toxin family.
Ashwood L, Elnahriry K, Stewart Z, Shafee T, Naseem M, Szanto T
BMC Biol. 2023; 21(1):121.
PMID: 37226201
PMC: 10210398.
DOI: 10.1186/s12915-023-01617-y.
Cone snail species off the Brazilian coast and their venoms: a review and update.
Fiorotti H, Figueiredo S, Campos F, Pimenta D
J Venom Anim Toxins Incl Trop Dis. 2023; 29:e20220052.
PMID: 36756364
PMC: 9897318.
DOI: 10.1590/1678-9199-JVATITD-2022-0052.
Characterization and Chemical Synthesis of Cm39 (α-KTx 4.8): A Scorpion Toxin That Inhibits Voltage-Gated K Channel K1.2 and Small- and Intermediate-Conductance Ca-Activated K Channels K2.2 and K3.1.
Naseem M, Gurrola-Briones G, Romero-Imbachi M, Borrego J, Carcamo-Noriega E, Beltran-Vidal J
Toxins (Basel). 2023; 15(1).
PMID: 36668861
PMC: 9866218.
DOI: 10.3390/toxins15010041.
Purification and Characterization of Bot33: A Non-Toxic Peptide from the Venom of Scorpion.
ElFessi R, Khamessi O, Srairi-Abid N, Sabatier J, Tytgat J, Peigneur S
Molecules. 2022; 27(21).
PMID: 36364113
PMC: 9657394.
DOI: 10.3390/molecules27217278.
The non-glycosylated protein of Toxocara canis MUC-1 interacts with proteins of murine macrophages.
Zhou R, Jia H, Du Z, Jiang A, Song Z, Wang T
PLoS Negl Trop Dis. 2022; 16(9):e0010734.
PMID: 36054186
PMC: 9477421.
DOI: 10.1371/journal.pntd.0010734.
Cm28, a scorpion toxin having a unique primary structure, inhibits KV1.2 and KV1.3 with high affinity.
Naseem M, Carcamo-Noriega E, Beltran-Vidal J, Borrego J, Szanto T, Zamudio F
J Gen Physiol. 2022; 154(8).
PMID: 35699659
PMC: 9202693.
DOI: 10.1085/jgp.202213146.
In vivo spatiotemporal control of voltage-gated ion channels by using photoactivatable peptidic toxins.
Montnach J, Blomer L, Lopez L, Filipis L, Meudal H, Lafoux A
Nat Commun. 2022; 13(1):417.
PMID: 35058427
PMC: 8776733.
DOI: 10.1038/s41467-022-27974-w.
Comparison of K Channel Families.
Taura J, Kircher D, Gameiro-Ros I, Slesinger P
Handb Exp Pharmacol. 2021; 267:1-49.
PMID: 34247281
DOI: 10.1007/164_2021_460.
Peptide Toxins Targeting KV Channels.
Matsumura K, Yokogawa M, Osawa M
Handb Exp Pharmacol. 2021; 267:481-505.
PMID: 34117930
DOI: 10.1007/164_2021_500.
Synthetic hookworm-derived peptides are potent modulators of primary human immune cell function that protect against experimental colitis in vivo.
Smallwood T, Navarro S, Cristofori-Armstrong B, Watkins T, Tungatt K, Ryan R
J Biol Chem. 2021; 297(1):100834.
PMID: 34051231
PMC: 8239465.
DOI: 10.1016/j.jbc.2021.100834.
Discovery of K 1.3 ion channel inhibitors: Medicinal chemistry approaches and challenges.
Gubic S, Hendrickx L, Toplak Z, Sterle M, Peigneur S, Tomasic T
Med Res Rev. 2021; 41(4):2423-2473.
PMID: 33932253
PMC: 8252768.
DOI: 10.1002/med.21800.